Table 2.
Radioisotopes | Emitting | Labeled | Mechanism of DNA Damage | DNA Repair Pathways | Biomarkers | Ref. |
---|---|---|---|---|---|---|
223Ra | α-emitter | - | DNA DSB and clustered DNA damage | NHEJ |
|
[52,53,54,58] |
212Pb | α-emitter | - | DNA DSB | HR |
|
[59,60,61] |
HER2 | ||||||
TCMC | ||||||
213Bi | α-emitter | E-cadherin | - | - |
|
[62,63,64] |
CD20 |
|
|||||
CD45 | Irreversible DNA DSB | NHEJ |
|
|||
125I | AE | - | DNA DSB | - | - | [100,108,109] |
CEA | DNA DSB and ROS-mediated pathway | - | Enhanced formation of 53BP1 and γ-H2AX foci | |||
111In | AE | γH2AX | Lethal DNA DSB damage | - | Enhanced formation of ɤ-H2AX foci | [103,104,106,107] |
Anti-CD33 | ||||||
anti-HER2 | Induced significant DNA DSBs | |||||
99mTc | AE | HYNIC-DAPI | Induced SSBs and DSBs via a direct interaction with DNA | - | - | [99] |
177Lu | β-emitter | DOTATATE | Induction of indirect DNA damage through ROS generation and formation of SSBs | - | Slightly increased γH2AX and pATM | [137] |
DOTATATE and DOTATOC | time- and dose-dependent induction of DNA-DSBs | Enhanced formation of γ-H2AX and 53BP1 nuclear foci | [126,135,136] | |||
PSMA | ||||||
HER2 | DNA DSBs | NEHJ |
|
[138] | ||
DOTA-JR11, SSTR antagonist DOTA-octreotide, SSTR agonist |
Reversable DNA DSBs | - | Enhanced the formation of 53BP1 and γ-H2AX foci | [132] | ||
EDTMP and DOTMP | - |
|
[143] | |||
Minigastrin analog | - | Activation of DNA damage response by p53 | - | [145] | ||
90Y | β-emitter | - | Induction of indirect DNA damage through ROS generation and formation of SSBs | NEHJ | - | [68,123] |
131I | β-emitter | - | Induction of indirect DNA damage through ROS | -- |
|
[153,154] |
89Sr | β-emitter | - | - | - |
|
[141,151] |
HR: homologous recombination, NHEJ: non-homologous end joining, SSB: single-strand break, DSB: double-strand break, β: beta, α: alpha, 223Ra: rhodium-223, AEs: Auger electrons, 212Bi: bismuth-212, 125I: iodine-125, 111In: indium-111, 99mTc: technetium-99m, 177Lu: lutetium-177, 131I: iodine-131, 90Y: yttrium-90, 89Sr: strontium-89, γ-H2AX: gamma-H2AX, 53BP1: p53-binding protein 1, CEA: carcinoembryonic antigen, DAPI: 4,6-diamidino-2-phenylindole, HYNIC (6-hydrazinonicotinic), FasL: CD95 ligand, FasR: CD95 receptor, bcl-2: B-cell lymphoma 2, EDTMP: ethylenediamine tetramethylene phosphonic, GADD45: growth arrest and DNA damage-45, PARP: poly(ADP-ribose) polymerase.